Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0001470831-26-000714

Chief Executive Officer sold 10,000 shares at an average $28.42 ($284,198)

  • Chief Executive Officer acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mazumdar Claire Chief Executive Officer 2026-07-10 Option exercise 10b5-1 +10,000 $3.79 $37,898 372,152 D
Mazumdar Claire Chief Executive Officer 2026-07-10 Sale 10b5-1 −9,972 $28.42 $283,367 362,180 D
Mazumdar Claire Chief Executive Officer 2026-07-10 Sale 10b5-1 −28 $29.68 $831 362,152 D
Derivatives
Mazumdar Claire Chief Executive Officer 2026-07-10 Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 120,546 D
Open-market sales · 10,000 sh · avg $28.42 · $284,198
Loading xslF345X06/wk-form4_1784060551.xml…